Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Vitamin D receptor is crucial for starting hair growth after birth.

IGF-1 injections help mice grow more hair by increasing cell growth and blocking a hair growth inhibitor.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

K16 can partially replace K14 but causes hair loss and skin issues.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

Pitx2 helps outer root sheath cells differentiate but can't start hair growth on its own.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Researchers created rat liver stem cells that could help repair liver failure in rats and may be useful for studying human liver diseases.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Far-infrared radiation improves stem cell growth and movement, helping heart therapy.

Genetic variations affecting skin structure play a key role in severe acne.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.

Damaging mitochondrial DNA in mice speeds up aging due to increased reactive oxygen species, not through the p53/p21 pathway.

Ginsenoside F2 from ginseng may increase hair growth better than standard treatments by affecting cell growth signals.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

A new skin-whitening agent using a peptide from wheat is safe and effective at reducing skin pigmentation.

Too much thymosin beta4 causes weird teeth and more hair growth in mice.

Adiponectin boosts lipid production in skin cells, potentially helping treat skin conditions with low sebum.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The study concluded that PKP1 is essential for skin integrity and hair growth, and its dysfunction causes the symptoms of ectodermal dysplasia/skin fragility syndrome.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New genetic factors linked to acne risk were discovered, highlighting the role of certain pathways and genes.

Cyclosporine A promotes hair growth and prolongs the active growth phase in human hair follicles, but may work differently than in rodents.

Adenosine helps hair grow longer and stronger by boosting certain growth factors and signaling pathways.